1. Home
  2. PSTV vs CHNR Comparison

PSTV vs CHNR Comparison

Compare PSTV & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • CHNR
  • Stock Information
  • Founded
  • PSTV 1996
  • CHNR N/A
  • Country
  • PSTV United States
  • CHNR Hong Kong
  • Employees
  • PSTV N/A
  • CHNR N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • CHNR Precious Metals
  • Sector
  • PSTV Health Care
  • CHNR Basic Materials
  • Exchange
  • PSTV Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • PSTV 8.6M
  • CHNR 8.6M
  • IPO Year
  • PSTV N/A
  • CHNR 1995
  • Fundamental
  • Price
  • PSTV $1.82
  • CHNR $0.76
  • Analyst Decision
  • PSTV Strong Buy
  • CHNR
  • Analyst Count
  • PSTV 1
  • CHNR 0
  • Target Price
  • PSTV $8.00
  • CHNR N/A
  • AVG Volume (30 Days)
  • PSTV 41.1K
  • CHNR 715.7K
  • Earning Date
  • PSTV 08-12-2024
  • CHNR 05-16-2023
  • Dividend Yield
  • PSTV N/A
  • CHNR N/A
  • EPS Growth
  • PSTV N/A
  • CHNR N/A
  • EPS
  • PSTV N/A
  • CHNR N/A
  • Revenue
  • PSTV $6,084,000.00
  • CHNR N/A
  • Revenue This Year
  • PSTV $5.21
  • CHNR N/A
  • Revenue Next Year
  • PSTV N/A
  • CHNR N/A
  • P/E Ratio
  • PSTV N/A
  • CHNR N/A
  • Revenue Growth
  • PSTV 733.42
  • CHNR N/A
  • 52 Week Low
  • PSTV $0.97
  • CHNR $0.61
  • 52 Week High
  • PSTV $3.21
  • CHNR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 51.37
  • CHNR 45.87
  • Support Level
  • PSTV $1.40
  • CHNR $0.71
  • Resistance Level
  • PSTV $1.59
  • CHNR $0.82
  • Average True Range (ATR)
  • PSTV 0.16
  • CHNR 0.09
  • MACD
  • PSTV 0.04
  • CHNR 0.01
  • Stochastic Oscillator
  • PSTV 78.15
  • CHNR 30.67

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About CHNR China Natural Resources Inc.

China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.

Share on Social Networks: